touchONCOLOGY joins Dr Luis Raez (Memorial Cancer institute, Memorial Healthcare System, Hollywood, FL, USA) at WCLC 2021 to discuss the latest advances in immunotherapies and targeted therapies in lung cancer.
Questions
1. Despite advances in the treatment of most types of cancer, lung cancer prognosis remains poor – what types of immunotherapies and targeted therapies have been under investigation to improve disease outcomes? (00:30-03:22)
2. How have these treatments impacted patient outcomes? (03:22-03:51)
3. What remain the greatest challenges to the use of immunotherapy and targeted therapies in the treatment of lung cancer? (05:51-04:58)
4. Are there any particular developments you would like to see in immunotherapy and targeted therapies in the treatment of lung cancer? (04:58-06:09)
Disclosures: Luis Raez has no financial or non-financial conflicts of interest to declare in relation to this video.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Sophie Nickelson.
Filmed in coverage of the 2021 WCLC Annual Meeting.
